ORG 2766

Drug Profile

ORG 2766

Latest Information Update: 08 Jan 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon
  • Developer Nonindustrial source; Organon
  • Class Anterior pituitary hormones; Hypothalamic hormones; Peptide fragments
  • Mechanism of Action Adenylate cyclase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Autistic disorder; Dementia; Diabetic neuropathies; Neurological disorders

Most Recent Events

  • 08 Jan 2001 Discontinued - Unspecified in Anxiety disorders in Netherlands (PO)
  • 08 Jan 2001 Discontinued - Unspecified in Autism in Netherlands (PO)
  • 03 Feb 1997 Discontinued-III for Dementia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top